Logo
Login
Subscribe
Logo
Login
Subscribe
The 4mm

Get smarter about dermatology

The most impactful dermatology news, curated by a dermatologist and delivered in a 5-minute weekly email. We scan 70+ sources so you don’t have to.

100% free. Personal emails (e.g. Gmail) work best

Previous Articles

⚡Anti-KIT in CSU, Povorcitinib for Vitiligo, and Guselkumab in PsA

Jun 21, 2025

⚡Anti-KIT in CSU, Povorcitinib for Vitiligo, and Guselkumab in PsA

⚡First Oral FASN Inhibitor for Acne

Jun 14, 2025

⚡First Oral FASN Inhibitor for Acne

⚡Two Firsts in SCC, Landmark Botox Trial, and Ucenprubart For AD

Jun 7, 2025

⚡Two Firsts in SCC, Landmark Botox Trial, and Ucenprubart For AD

⚡Opzelura In Pediatric AD, AI Melanoma Launch, and Cabtreo Vs Epiduo Forte

May 31, 2025

⚡Opzelura In Pediatric AD, AI Melanoma Launch, and Cabtreo Vs Epiduo Forte

⚡First ITK Blocker in Atopic Dermatitis

May 24, 2025

⚡First ITK Blocker in Atopic Dermatitis

⚡Zoryve for Psoriasis, BTK Inhibitors Miss, and Keloid Protocol With Durable Results

May 10, 2025

⚡Zoryve for Psoriasis, BTK Inhibitors Miss, and Keloid Protocol With Durable Results

Load more

The 4mm

The most impactful dermatology news, curated by a dermatologist and delivered in a 5-minute weekly email. We scan 70+ sources so you don’t have to.

Home

Posts

© 2025 The 4mm.

Privacy policy

Terms of use

Powered by beehiiv